Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders

Blood Reviews

Volumn 27, Issue 4, 2013, Pages 167-178

  Da Costa, Lydie ^a,b,c,d   Galimand, Julie ^a   Fenneteau, Odile ^a   Mohandas, Narla ^e  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d Laboratoire d'Excellence GR Ex   (France)

^e NEW YORK BLOOD CENTER   (United States)

Author keywords

Elliptocytosis; Hemolysis; Hereditary spherocytosis; Pyropoikilocytosis; Red cell membrane; Stomatocytosis

Indexed keywords

CELL MEMBRANE PROTEIN; SPECTRIN; ANKYRIN;

ANEMIA; ANK1 GENE; ARTICLE; CHOLECYSTECTOMY; CLINICAL FEATURE; CYTOLOGY; CYTOSKELETON; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EKTACYTOMETRY; ELLIPTOCYTOSIS; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FRAGILITY; ERYTHROCYTE STRUCTURE; FLOW CYTOMETRY; GENE; GENE MUTATION; HEMOLYSIS; HEREDITARY SPHEROCYTOSIS; HUMAN; JAUNDICE; LIPID BILAYER; MEMBRANE STRUCTURE; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; NONHUMAN; OSMOTIC FRAGILITY; PALLOR; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN ELECTROPHORESIS; SPLENECTOMY; STOMATOCYTOSIS; BLOOD; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; GENETICS; PATHOLOGY; PYROPOIKILOCYTOSIS; REVIEW; DEFICIENCY; ELLIPTOCYTOSIS, HEREDITARY; SPHEROCYTOSIS, HEREDITARY;

ELLIPTOCYTOSIS; HEMOLYSIS; HEREDITARY SPHEROCYTOSIS; PYROPOIKILOCYTOSIS; RED CELL MEMBRANE; STOMATOCYTOSIS;

ANKYRINS; ELLIPTOCYTOSIS, HEREDITARY; ERYTHROCYTES; HUMANS; SPHEROCYTOSIS, HEREDITARY;

EID: 84881376528     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2013.04.003     Document Type: Article

References (145)

1. An X., Mohandas N. Disorders of red cell membrane. Br J Haematol 2008, 141(3):367-375.
2. Gallagher P.G. Red cell membrane disorders. Hematology Am Soc Hematol Educ Program 2005, 13-18.
3. Iolascon A., Piscopo C., Boschetto L. Red cell membrane disorders in pediatrics. Pediatr Ann 2008, 37(5):295-301.
4. Iolascon A., Perrotta S., Stewart G.W. Red blood cell membrane defects. Rev Clin Exp Hematol 2003, 7(1):22-56.
5. Mohandas N., Gallagher P.G. Red cell membrane: past, present, and future. Blood 2008, 112(10):3939-3948.
6. Perrotta S., Gallagher P.G., Mohandas N. Hereditary spherocytosis. Lancet 2008, 372(9647):1411-1426.
7. Warkentin T.E., Barr R.D., Ali M.A., Mohandas N. Recurrent acute splenic sequestration crisis due to interacting genetic defects: hemoglobin SC disease and hereditary spherocytosis. Blood 1990, 75(1):266-270.
8. Yang Y.M., Donnell C., Wilborn W., Goodman S.R., Files B., Moore R.B., et al. Splenic sequestration associated with sickle cell trait and hereditary spherocytosis. Am J Hematol 1992, 40(2):110-116.
9. An X., Guo X., Gratzer W., Mohandas N. Phospholipid binding by proteins of the spectrin family: a comparative study. Biochem Biophys Res Commun 2005, 327(3):794-800.
10. An X., Guo X., Sum H., Morrow J., Gratzer W., Mohandas N. Phosphatidylserine binding sites in erythroid spectrin: location and implications for membrane stability. Biochemistry 2004, 43(2):310-315.
11. An X., Zhang X., Debnath G., Baines A.J., Mohandas N. Phosphatidylinositol-4,5-biphosphate (PIP2) differentially regulates the interaction of human erythrocyte protein 4.1 (4.1R) with membrane proteins. Biochemistry 2006, 45(18):5725-5732.
12. Manno S., Mohandas N., Takakuwa Y. ATP-dependent mechanism protects spectrin against glycation in human erythrocytes. J Biol Chem 2010, 285(44):33923-33929.
13. Manno S., Takakuwa Y., Mohandas N. Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc Natl Acad Sci U S A 2002, 99(4):1943-1948.
14. Chasis J.A., Mohandas N. Red blood cell glycophorins. Blood 1992, 80(8):1869-1879.
15. Mohandas N., An X. New insights into function of red cell membrane proteins and their interaction with spectrin-based membrane skeleton. Transfus Clin Biol 2006, 13(1-2):29-30.
16. Reid M.E., Mohandas N. Red blood cell blood group antigens: structure and function. Semin Hematol 2004, 41(2):93-117.
17. An X., Lecomte M.C., Chasis J.A., Mohandas N., Gratzer W. Shear-response of the spectrin dimer-tetramer equilibrium in the red blood cell membrane. J Biol Chem 2002, 277(35):31796-31800.
18. An X., Salomao M., Guo X., Gratzer W., Mohandas N. Tropomyosin modulates erythrocyte membrane stability. Blood 2007, 109(3):1284-1288.
19. Ballas S.K., Mohandas N., Clark M.R., Shohet S.B. Rheological properties of antibody-coated red cells. Transfusion 1984, 24(2):124-129.
20. Mohandas N. Molecular basis for red cell membrane viscoelastic properties. Biochem Soc Trans 1992, 20(4):776-782.
21. Mohandas N., Chasis J.A. Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol 1993, 30(3):171-192.
22. Mohandas N., Chasis J.A., Shohet S.B. The influence of membrane skeleton on red cell deformability, membrane material properties, and shape. Semin Hematol 1983, 20(3):225-242.
23. Mohandas N., Evans E. Mechanical properties of the red cell membrane in relation to molecular structure and genetic defects. Annu Rev Biophys Biomol Struct 1994, 23:787-818.
24. Mohandas N., Phillips W.M., Bessis M. Red blood cell deformability and hemolytic anemias. Semin Hematol 1979, 16(2):95-114.
25. Mohandas N., Shohet S.B. Control of red cell deformability and shape. Curr Top Hematol 1978, 1:71-125.
26. Montel-Hagen A., Sitbon M., Taylor N. Erythroid glucose transporters. Curr Opin Hematol 2009, 16(3):165-172.
27. Van Kim C.L., Colin Y., Cartron J.P. Rh proteins: key structural and functional components of the red cell membrane. Blood Rev 2006, 20(2):93-110.
28. Cartron J.P., Colin Y. Structural and functional diversity of blood group antigens. Transfus Clin Biol 2001, 8(3):163-199.
29. Telen M.J. Erythrocyte blood group antigens: not so simple after all. Blood 1995, 85(2):299-306.
30. Anong W.A., Franco T., Chu H., Weis T.L., Devlin E.E., Bodine D.M., et al. Adducin forms a bridge between the erythrocyte membrane and its cytoskeleton and regulates membrane cohesion. Blood 2009, 114(9):1904-1912.
31. Bruce L.J., Beckmann R., Ribeiro M.L., Peters L.L., Chasis J.A., Delaunay J., et al. A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood 2003, 101(10):4180-4188.
32. Mohandas N., Narla A. Blood group antigens in health and disease. Curr Opin Hematol 2005, 12(2):135-140.
33. Parsons S.F., Spring F.A., Chasis J.A., Anstee D.J. Erythroid cell adhesion molecules Lutheran and LW in health and disease. Baillieres Best Pract Res Clin Haematol 1999, 12(4):729-745.
34. Salomao M., Zhang X., Yang Y., Lee S., Hartwig J.H., Chasis J.A., et al. Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane. Proc Natl Acad Sci U S A 2008, 105(23):8026-8031.
35. Ribeiro M.L., Alloisio N., Almeida H., Gomes C., Texier P., Lemos C., et al. Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3. Blood 2000, 96(4):1602-1604.
36. Whitfield C.F., Follweiler J.B., Lopresti-Morrow L., Miller B.A. Deficiency of alpha-spectrin synthesis in burst-forming units-erythroid in lethal hereditary spherocytosis. Blood 1991, 78(11):3043-3051.
37. Gallagher P.G., Weed S.A., Tse W.T., Benoit L., Morrow J.S., Marchesi S.L., et al. Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene. J Clin Invest 1995, 95(3):1174-1182.
38. Cynober T., Mohandas N., Tchernia G. Red cell abnormalities in hereditary spherocytosis: relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med 1996, 128(3):259-269.
39. Da Costa L., Mohandas N., Sorette M., Grange M.J., Tchernia G., Cynober T. Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia. Blood 2001, 98(10):2894-2899.
40. Agre P., Casella J.F., Zinkham W.H., McMillan C., Bennett V. Partial deficiency of erythrocyte spectrin in hereditary spherocytosis. Nature 1985, 314(6009):380-383.
41. Delaunay J. Molecular basis of red cell membrane disorders. Acta Haematol 2002, 108(4):210-218.
42. del Giudice E.M., Hayette S., Bozon M., Perrotta S., Alloisio N., Vallier A., et al. Ankyrin Napoli: a de novo deletional frameshift mutation in exon 16 of ankyrin gene (ANK1) associated with spherocytosis. Br J Haematol 1996, 93(4):828-834.
43. Eber S.W., Gonzalez J.M., Lux M.L., Scarpa A.L., Tse W.T., Dornwell M., et al. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet 1996, 13(2):214-218.
44. Eber S., Lux S.E. Hereditary spherocytosis-defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol 2004, 41(2):118-141.
45. Lux S.E., Tse W.T., Menninger J.C., John K.M., Harris P., Shalev O., et al. Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature 1990, 345(6277):736-739.
46. Palek J., Lux S.E. Red cell membrane skeletal defects in hereditary and acquired hemolytic anemias. Semin Hematol 1983, 20(3):189-224.
47. Jarolim P., Murray J.L., Rubin H.L., Taylor W.M., Prchal J.T., Ballas S.K., et al. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood 1996, 88(11):4366-4374.
48. Hassoun H., Vassiliadis J.N., Murray J., Njolstad P.R., Rogus J.J., Ballas S.K., et al. Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency. Blood 1997, 90(1):398-406.
49. Bessis M. Red cell shapes. An illustrated classification and its rationale. Nouv Rev Fr Hematol 1972, 12(6):721-745.
50. Saada V., Cynober T., Brossard Y., Schischmanoff P.O., Sender A., Cohen H., et al. Incidence of hereditary spherocytosis in a population of jaundiced neonates. Pediatr Hematol Oncol 2006, 23(5):387-397.
51. Clark M.R. Mean corpuscular hemoglobin concentration and cell deformability. Ann N Y Acad Sci 1989, 565:284-294.
52. Mohandas N., Kim Y.R., Tycko D.H., Orlik J., Wyatt J., Groner W. Accurate and independent measurement of volume and hemoglobin concentration of individual red cells by laser light scattering. Blood 1986, 68(2):506-513.
53. Bolton-Maggs P.H., Langer J.C., Iolascon A., Tittensor P., King M.J. Guidelines for the diagnosis and management of hereditary spherocytosis-2011 update. Br J Haematol 2012, 156(1):37-49.
54. Parpart A.K., Lorenz P.B., Papart E.R., Gregg J.R., Chase A.M. The osmotic resistance (fragility) of human red cells. J Clin Invest 1947, 26(4):636-640.
55. Gottfried E.L., Robertson N.A. Glycerol lysis time of incubated erythrocytes in the diagnosis of hereditary spherocytosis. J Lab Clin Med 1974, 84(5):746-751.
56. Bucx M.J., Breed W.P., Hoffmann J.J. Comparison of acidified glycerol lysis test, Pink test and osmotic fragility test in hereditary spherocytosis: effect of incubation. Eur J Haematol 1988, 40(3):227-231.
57. Guitton C., Garcon L., Cynober T., Gauthier F., Tchernia G., Delaunay J., et al. Hereditary spherocytosis: guidelines for the diagnosis and management in children. Arch Pediatr 2008, 15(9):1464-1473.
58. Bianchi P., Fermo E., Vercellati C., Marcello A.P., Porretti L., Cortelezzi A., et al. Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics. Haematologica 2012, 97(4):516-523.
59. Kobayashi K., Hamaki T., Ohwada A., Tomiyama J., Sakuma R., Mizuta Y., et al. Low-titer cold agglutinin disease following Salmonella gastroenteritis. Rinsho Ketsueki 2011, 52(1):32-36.
60. D'Alcamo E., Agrigento V., Sclafani S., Vitrano A., Cuccia L., Maggio A., et al. Reliability of EMA binding test in the diagnosis of hereditary spherocytosis in Italian patients. Acta Haematol 2011, 125(3):136-140.
61. King M.J., Jepson M.A., Guest A., Mushens R. Detection of hereditary pyropoikilocytosis by the eosin-5-maleimide (EMA)-binding test is attributable to a marked reduction in EMA-reactive transmembrane proteins. Int J Lab Hematol 2011, 33(2):205-211.
62. Riley C.H., Nikolajsen K., Kjaersgaard E., Klausen T.W., Mourits-Andersen T., Clausen N., et al. Flow cytometric diagnostics of hereditary spherocytosis. Ugeskr Laeger 2009, 171(49):3610-3614.
63. Tachavanich K., Tanphaichitr V.S., Utto W., Viprakasit V. Rapid flow cytometric test using eosin-5-maleimide for diagnosis of red blood cell membrane disorders. Southeast Asian J Trop Med Public Health 2009, 40(3):570-575.
64. Koscielak J., Mendek-Czajkowska E., Spychalska J., Marosz-Rudnicka A., Myslinska A., Adamowicz-Salach A., et al. A case of hereditary over-hydrated stomatocytosis with stomatospherocytes and spherocytes in the blood. Med Wieku Rozwoj 2009, 13(2):131-135.
65. Kar R., Rao S., Srinivas U.M., Mishra P., Pati H.P. Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India. Hematology 2009, 14(3):164-167.
66. Kar R., Mishra P., Pati H.P. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis. Int J Lab Hematol 2010, 32(1 Pt 2):8-16.
67. King M.J., Telfer P., MacKinnon H., Langabeer L., McMahon C., Darbyshire P., et al. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. Cytometry B Clin Cytom 2008, 74(4):244-250.
68. King M.J., Smythe J.S., Mushens R. Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis. Br J Haematol 2004, 124(1):106-113.
69. Kedar P.S., Colah R.B., Kulkarni S., Ghosh K., Mohanty D. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders. Clin Lab Haematol 2003, 25(6):373-376.
70. King M.J., Behrens J., Rogers C., Flynn C., Greenwood D., Chambers K. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol 2000, 111(3):924-933.
71. Crisp R.L., Solari L., Vota D., Garcia E., Miguez G., Chamorro M.E., et al. A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5'-maleimide flow cytometry, osmotic fragility test, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in Argentina. Ann Hematol 2011, 90(6):625-634.
72. Girodon F., Garcon L., Bergoin E., Largier M., Delaunay J., Feneant-Thibault M., et al. Usefulness of the eosin-5'-maleimide cytometric method as a first-line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis. Br J Haematol 2008, 140(4):468-470.
73. Zanella A., Izzo C., Rebulla P., Zanuso F., Perroni L., Sirchia G. Acidified glycerol lysis test: a screening test for spherocytosis. Br J Haematol 1980, 45(3):481-486.
74. Mohandas N., Clark M.R., Jacobs M.S., Groner W., Shohet S.B. Ektacytometric analysis of factors regulating red cell deformability. Blood Cells 1980, 6(3):329-334.
75. Mohandas N., Clark M.R., Health B.P., Rossi M., Wolfe L.C., Lux S.E., et al. A technique to detect reduced mechanical stability of red cell membranes: relevance to elliptocytic disorders. Blood 1982, 59(4):768-774.
76. Fairbanks G., Steck T.L., Wallach D.F. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 1971, 10(13):2606-2617.
77. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685.
78. Delaunay J., Stewart G., Iolascon A. Hereditary dehydrated and overhydrated stomatocytosis: recent advances. Curr Opin Hematol 1999, 6(2):110-114.
79. Gallagher P.G., Ferreira J.D., Costa F.F., Saad S.T., Forget B.G. A recurrent frameshift mutation of the ankyrin gene associated with severe hereditary spherocytosis. Br J Haematol 2000, 111(4):1190-1193.
80. Bracher N.A., Lyons C.A., Wessels G., Mansvelt E., Coetzer T.L. Band 3 Cape Town (E90K) causes severe hereditary spherocytosis in combination with band 3 Prague III. Br J Haematol 2001, 113(3):689-693.
81. Alloisio N., Maillet P., Carre G., Texier P., Vallier A., Baklouti F., et al. Hereditary spherocytosis with band 3 deficiency. Association with a nonsense mutation of the band 3 gene (allele Lyon), and aggravation by a low-expression allele occurring in trans (allele Genas). Blood 1996, 88(3):1062-1069.
82. Gallagher P.G., Forget B.G. Hematologically important mutations: band 3 and protein 4.2 variants in hereditary spherocytosis. Blood Cells Mol Dis 1997, 23(3):417-421.
83. Wichterle H., Hanspal M., Palek J., Jarolim P. Combination of two mutant alpha spectrin alleles underlies a severe spherocytic hemolytic anemia. J Clin Invest 1996, 98(10):2300-2307.
84. Jarolim P., Wichterle H., Hanspal M., Murray J., Rubin H.L., Palek J. Beta spectrin PRAGUE: a truncated beta spectrin producing spectrin deficiency, defective spectrin heterodimer self-association and a phenotype of spherocytic elliptocytosis. Br J Haematol 1995, 91(2):502-510.
85. Dhermy D., Steen-Johnsen J., Bournier O., Hetet G., Cynober T., Tchernia G., et al. Coinheritance of two alpha-spectrin gene defects in a recessive spherocytosis family. Clin Lab Haematol 2000, 22(6):329-336.
86. Delaunay J., Nouyrigat V., Proust A., Schischmanoff P.O., Cynober T., Yvart J., et al. Different impacts of alleles alphaLEPRA and alphaLELY as assessed versus a novel, virtually null allele of the SPTA1 gene in trans. Br J Haematol 2004, 127(1):118-122.
87. Tchernia G., Delhommeau F., Perrotta S., Cynober T., Bader-Meunier B., Nobili B., et al. Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis. Hematol J 2000, 1(3):146-152.
88. Danielson P.D., Shaul D.B., Phillips J.D., Stein J.E., Anderson K.D. Technical advances in pediatric laparoscopy have had a beneficial impact on splenectomy. J Pediatr Surg 2000, 35(11):1578-1581.
89. Price V.E., Blanchette V.S., Ford-Jones E.L. The prevention and management of infections in children with asplenia or hyposplenia. Infect Dis Clin North Am 2007, 21(3):697-710. [viii-ix].
90. Tchernia G., Gauthier F., Mielot F., Dommergues J.P., Yvart J., Chasis J.A., et al. Initial assessment of the beneficial effect of partial splenectomy in hereditary spherocytosis. Blood 1993, 81(8):2014-2020.
91. Tchernia G., Bader-Meunier B., Berterottiere P., Eber S., Dommergues J.P., Gauthier F. Effectiveness of partial splenectomy in hereditary spherocytosis. Curr Opin Hematol 1997, 4(2):136-141.
92. de Buys Roessingh A.S., de Lagausie P., Rohrlich P., Berrebi D., Aigrain Y. Follow-up of partial splenectomy in children with hereditary spherocytosis. J Pediatr Surg 2002, 37(10):1459-1463.
93. Rice H.E., Oldham K.T., Hillery C.A., Skinner M.A., O'Hara S.M., Ware R.E. Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children. Ann Surg 2003, 237(2):281-288.
94. Dutta S., Price V.E., Blanchette V., Langer J.C. A laparoscopic approach to partial splenectomy for children with hereditary spherocytosis. Surg Endosc 2006, 20(11):1719-1724.
95. Casale M., Perrotta S. Splenectomy for hereditary spherocytosis: complete, partial or not at all?. Expert Rev Hematol 2011, 4(6):627-635.
96. Buesing K.L., Tracy E.T., Kiernan C., Pastor A.C., Cassidy L.D., Scott J.P., et al. Partial splenectomy for hereditary spherocytosis: a multi-institutional review. J Pediatr Surg 2011, 46(1):178-183.
97. Slater B.J., Chan F.P., Davis K., Dutta S. Institutional experience with laparoscopic partial splenectomy for hereditary spherocytosis. J Pediatr Surg 2010, 45(8):1682-1686.
98. Hollingsworth C.L., Rice H.E. Hereditary spherocytosis and partial splenectomy in children: review of surgical technique and the role of imaging. Pediatr Radiol 2010, 40(7):1177-1183.
99. Tracy E.T., Rice H.E. Partial splenectomy for hereditary spherocytosis. Pediatr Clin North Am 2008, 55(2):503-519. [x].
100. Hery G., Becmeur F., Mefat L., Kalfa D., Lutz P., Lutz L., et al. Laparoscopic partial splenectomy: indications and results of a multicenter retrospective study. Surg Endosc 2008, 22(1):45-49.
101. Sandler A., Winkel G., Kimura K., Soper R. The role of prophylactic cholecystectomy during splenectomy in children with hereditary spherocytosis. J Pediatr Surg 1999, 34(7):1077-1078.
102. del Giudice E.M., Perrotta S., Nobili B., Specchia C., d'Urzo G., Iolascon A. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 1999, 94(7):2259-2262.
103. Shao T., Yang Y.X. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol 2005, 100(8):1813-1820.
104. Alizai N.K., Richards E.M., Stringer M.D. Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis?. Arch Dis Child 2010, 95(8):596-599.
105. Delaunay J., Alloisio N., Morle L., Baklouti F., Dalla Venezia N., Maillet P., et al. Molecular genetics of hereditary elliptocytosis and hereditary spherocytosis. Ann Genet 1996, 39(4):209-221.
106. Delaunay J., Dhermy D. Mutations involving the spectrin heterodimer contact site: clinical expression and alterations in specific function. Semin Hematol 1993, 30(1):21-33.
107. Gallagher P.G. Hereditary elliptocytosis: spectrin and protein 4.1R. Semin Hematol 2004, 41(2):142-164.
108. Iolascon A., King M.J., Robertson S., Avvisati R.A., Vitiello F., Asci R., et al. A genomic deletion causes truncation of alpha-spectrin and ellipto-poikilocytosis. Blood Cells Mol Dis 2011, 46(3):195-200.
109. Marchesi S.L., Knowles W.J., Morrow J.S., Bologna M., Marchesi V.T. Abnormal spectrin in hereditary elliptocytosis. Blood 1986, 67(1):141-151.
110. Marchesi S.L., Conboy J., Agre P., Letsinger J.T., Marchesi V.T., Speicher D.W., et al. Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. I. Biochemical identification of rearrangements in the spectrin/actin binding domain and functional characterizations. J Clin Invest 1990, 86(2):516-523.
111. Gaetani M., Mootien S., Harper S., Gallagher P.G., Speicher D.W. Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha spectrin tetramer site. Blood 2008, 111(12):5712-5720.
112. Johnson C.P., Gaetani M., Ortiz V., Bhasin N., Harper S., Gallagher P.G., et al. Pathogenic proline mutation in the linker between spectrin repeats: disease caused by spectrin unfolding. Blood 2007, 109(8):3538-3543.
113. Garbarz M., Lecomte M.C., Feo C., Devaux I., Picat C., Lefebvre C., et al. Hereditary pyropoikilocytosis and elliptocytosis in a white French family with the spectrin alpha I/74 variant related to a CGT to CAT codon change (Arg to His) at position 22 of the spectrin alpha I domain. Blood 1990, 75(8):1691-1698.
114. Garbarz M., Tse W.T., Gallagher P.G., Picat C., Lecomte M.C., Galibert F., et al. Spectrin Rouen (beta 220-218), a novel shortened beta-chain variant in a kindred with hereditary elliptocytosis. Characterization of the molecular defect as exon skipping due to a splice site mutation. J Clin Invest 1991, 88(1):76-81.
115. Iolascon A., Miraglia del Giudice E., Camaschella C. Molecular pathology of inherited erythrocyte membrane disorders: hereditary spherocytosis and elliptocytosis. Haematologica 1992, 77(1):60-72.
116. Lu Y.Q., Liu J.F., Huang C.H., Blumenfeld O.O., Schwartz R.S., Lawrence C., et al. Elliptocytosis associated with an abnormal alpha glycophorin. Ann Hematol 1992, 65(2):106-109.
117. Mootien S., Gallagher P.G. Hereditary pyropoikilocytosis and the spectrin St. Claude allele. Br J Haematol 2004, 124(2):251-252.
118. Alanio-Brechot C., Schischmanoff P.O., Feneant-Thibault M., Cynober T., Tchernia G., Delaunay J., et al. Association between myeloid malignancies and acquired deficit in protein 4.1R: a retrospective analysis of six patients. Am J Hematol 2008, 83(4):275-278.
119. Hur M., Lee K.M., Cho H.C., Park Y.I., Kim S.H., Chang Y.W., et al. Protein 4.1 deficiency and deletion of chromosome 20q are associated with acquired elliptocytosis in myelodysplastic syndrome. Clin Lab Haematol 2004, 26(1):69-72.
120. Ideguchi H., Yamada Y., Kondo S., Tamura K., Makino S., Hamasaki N. Abnormal erythrocyte band 4.1 protein in myelodysplastic syndrome with elliptocytosis. Br J Haematol 1993, 85(2):387-392.
121. Dhermy D., Schrevel J., Lecomte M.C. Spectrin-based skeleton in red blood cells and malaria. Curr Opin Hematol 2007, 14(3):198-202.
122. Gallagher P.G., Petruzzi M.J., Weed S.A., Zhang Z., Marchesi S.L., Mohandas N., et al. Mutation of a highly conserved residue of betaI spectrin associated with fatal and near-fatal neonatal hemolytic anemia. J Clin Invest 1997, 99(2):267-277.
123. Mentzer W.C., Iarocci T.A., Mohandas N., Lane P.A., Smith B., Lazerson J., et al. Modulation of erythrocyte membrane mechanical stability by 2,3-diphosphoglycerate in the neonatal poikilocytosis/elliptocytosis syndrome. J Clin Invest 1987, 79(3):943-949.
124. Dalla Venezia N., Wilmotte R., Morle L., Forissier A., Parquet N., Garbarz M., et al. An alpha-spectrin mutation responsible for hereditary elliptocytosis associated in cis with the alpha v/41 polymorphism. Hum Genet 1993, 90(6):641-644.
125. Wilmotte R., Marechal J., Morle L., Baklouti F., Philippe N., Kastally R., et al. Low expression allele alpha LELY of red cell spectrin is associated with mutations in exon 40 (alpha V/41 polymorphism) and intron 45 and with partial skipping of exon 46. J Clin Invest 1993, 91(5):2091-2096.
126. Mohandas N., An X. Malaria and human red blood cells. Med Microbiol Immunol 2012.
127. Rosanas-Urgell A., Lin E., Manning L., Rarau P., Laman M., Senn N., et al. Reduced Risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study. PLoS Med 2012, 9(9):e1001305.
128. Mohandas N., Lie-Injo L.E., Friedman M., Mak J.W. Rigid membranes of Malayan ovalocytes: a likely genetic barrier against malaria. Blood 1984, 63(6):1385-1392.
129. Liu S.C., Jarolim P., Rubin H.L., Palek J., Amato D., Hassan K., et al. The homozygous state for the band 3 protein mutation in Southeast Asian ovalocytosis may be lethal. Blood 1994, 84(10):3590-3591.
130. Delaunay J. The hereditary stomatocytoses: genetic disorders of the red cell membrane permeability to monovalent cations. Semin Hematol 2004, 41(2):165-172.
131. Grootenboer S., Schischmanoff P.O., Laurendeau I., Cynober T., Tchernia G., Dommergues J.P., et al. Pleiotropic syndrome of dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema maps to 16q23-q24. Blood 2000, 96(7):2599-2605.
132. Grootenboer S., Barro C., Cynober T., Olivier Schischmanoff P., Ayoubi J.M., Tchernia G., et al. Dehydrated hereditary stomatocytosis: a cause of prenatal ascites. Prenat Diagn 2001, 21(13):1114-1118.
133. Grootenboer-Mignot S., Cretien A., Laurendeau I., Poissonnier M.H., Doireau V., Brossard Y., et al. Sub-lethal hydrops as a manifestation of dehydrated hereditary stomatocytosis in two consecutive pregnancies. Prenat Diagn 2003, 23(5):380-384.
134. Carella M., Stewart G., Ajetunmobi J.F., Perrotta S., Grootenboer S., Tchernia G., et al. Genomewide search for dehydrated hereditary stomatocytosis (hereditary xerocytosis): mapping of locus to chromosome 16 (16q23-qter). Am J Hum Genet 1998, 63(3):810-816.
135. Houston B.L., Zelinski T., Israels S.J., Coghlan G., Chodirker B.N., Gallagher P.G., et al. Refinement of the hereditary xerocytosis locus on chromosome 16q in a large Canadian kindred. Blood Cells Mol Dis 2011, 47(4):226-231.
136. Zarychanski R., Schulz V.P., Houston B.L., Maksimova Y., Houston D.S., Smith B., et al. Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood 2012, 120(9):1908-1915.
137. Coste B., Mathur J., Schmidt M., Earley T.J., Ranade S., Petrus M.J., et al. Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science 2010, 330(6000):55-60.
138. Endeward V., Cartron J.P., Ripoche P., Gros G. RhAG protein of the Rhesus complex is a CO2 channel in the human red cell membrane. FASEB J 2008, 22(1):64-73.
139. Marini A.M., Matassi G., Raynal V., Andre B., Cartron J.P., Cherif-Zahar B. The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. Nat Genet 2000, 26(3):341-344.
140. Bruce L.J., Guizouarn H., Burton N.M., Gabillat N., Poole J., Flatt J.F., et al. The monovalent cation leak in overhydrated stomatocytic red blood cells results from amino acid substitutions in the Rh-associated glycoprotein. Blood 2009, 113(6):1350-1357.
141. Carella M., d'Adamo A.P., Grootenboer-Mignot S., Vantyghem M.C., Esposito L., D'Eustacchio A., et al. A second locus mapping to 2q35-36 for familial pseudohyperkalaemia. Eur J Hum Genet 2004, 12(12):1073-1076.
142. Iolascon A., Stewart G.W., Ajetunmobi J.F., Perrotta S., Delaunay J., Carella M., et al. Familial pseudohyperkalemia maps to the same locus as dehydrated hereditary stomatocytosis (hereditary xerocytosis). Blood 1999, 93(9):3120-3123.
143. Bruce L.J., Robinson H.C., Guizouarn H., Borgese F., Harrison P., King M.J., et al. Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1. Nat Genet 2005, 37(11):1258-1263.
144. Iolascon A., De Falco L., Borgese F., Esposito M.R., Avvisati R.A., Izzo P., et al. A novel erythroid anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis. Haematologica 2009, 94(8):1049-1059.
145. Olivieri O., Girelli D., Vettore L., Balercia G., Corrocher R. A case of congenital dyserythropoietic anaemia with stomatocytosis, reduced bands 7 and 8 and normal cation content. Br J Haematol 1992, 80(2):258-260.